semaglutide causing low blood sugar GLP-1 and Pressure: Symptoms, Risks, and Management 14 Dangerous Risks of Taking

J Vasc Interv Radiol 2004

Overview of Reported Adverse Health Events with Ozempic Ozempic, while lauded for its efficacy in managing Type 2 diabetes, has not been without controversy regarding potential adverse health events

Positive drug-abuse screen (excluding marijuana (tetrahydrocannabinol (THC)) before the first dose of study drug, unless the participant is prescribed one of these classes of drugs (narcotics) for a medically appropriate indication

In a separate report, NATAP reviewed results of a 24-week randomized trial that found greater liver fat reduction with the GLP-1/glucagon dual receptor agonist efinopegdutide than with the GLP-1 receptor agonist semaglutide [5]